Welcome to PROMISE!

1–2 minutes

Continuing the prediction and prevention goals of the PREDICTS, GEM, Nurses’ Health Study, MECONIUM Study and Road To Prevention Study cohorts, our team is excited to announce our collaboration through the PROMISE Consortium.

This initiative will explore early risk factors of Crohn’s disease and focus on targets to develop new prevention strategies. Stay in touch with us here!

A movement towards a healthier future for #CrohnsDisease patients, the #PROMISEConsortium explores early detection through omics, microbiome & immune system analysis. Our goal: to move beyond symptom management to predict & prevent: https://t.co/307Zelp2Fj #CrohnsResearch pic.twitter.com/xE4ksiCnpy
— Mount Sinai Genetics (@SinaiGenetics) January 25, 2024